# EDGAR Filing Document

**Accession Number:** 0000911216
**File Stem:** 0001493152-25-027267
**Filing Date:** 2025-12
**Character Count:** 7664
**Document Hash:** 16d8580e96f69bbca81fb189dd0462d5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-027267.hdr.sgml**: 20251211

**ACCESSION NUMBER**: 0001493152-25-027267

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251209

**FILED AS OF DATE**: 20251211

**DATE AS OF CHANGE**: 20251211

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** DUNTON ALAN W
- **CENTRAL INDEX KEY:** 0001304773

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15543
- **FILM NUMBER:** 251565644

**MAIL ADDRESS:**
- **STREET 1:** VICURON PHARMACEUTICALS INC
- **STREET 2:** 455 S GULPH ROAD SUITE 305
- **CITY:** KING OF PRUSSIA
- **STATE:** PA
- **ZIP:** 19406
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PALATIN TECHNOLOGIES INC
- **CENTRAL INDEX KEY:** 0000911216
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 954078884
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 4B CEDAR BROOK DRIVE
- **CITY:** CRANBURY
- **STATE:** NJ
- **ZIP:** 08512
- **BUSINESS PHONE:** 609-495-2200

**MAIL ADDRESS:**
- **STREET 1:** 4B CEDAR BROOK DRIVE
- **CITY:** CRANBURY
- **STATE:** NJ
- **ZIP:** 08512

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTERFILM INC
- **DATE OF NAME CHANGE:** 19930825

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>DUNTON ALAN W<br><sub>(Last) (First) (Middle)</sub><br>PALATIN TECHNOLOGIES, INC.<br>11 DEER PARK DRIVE, SUITE 204<br><sub>(Street)</sub><br>MONMOUTH JUNCTION,, NJ 08852<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-09 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PALATIN TECHNOLOGIES INC [ PTN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-12-09 |  | A |  | 1000<sup>(1)</sup> | A | 0<sup>(1)</sup> | 13081 | D |  |
| Common Stock | 2025-12-09 |  | A |  | 1000<sup>(2)</sup> | A | 0<sup>(2)</sup> | 14081 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | $21.38 | 2025-12-09 |  | A |  | 1200 |  | 2026-12-09<sup>(3)</sup> | 2035-12-09<sup>(3)</sup> | Common Stock | 1200 | $0 | 24799 | D |  |
| Stock Option (Right to Buy) | $21.38 | 2025-12-09 |  | A |  | 1200 |  | 2026-12-09<sup>(4)</sup> | 2026-12-09<sup>(4)</sup> | Common Stock | 1200 | $0 | 25999 | D |  |

---

### Footnotes:

(1) Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on December 9, 2026. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.

(2) Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units.

(3) Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9,2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the options.

(4) Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options.

**Signature:** /s/ Alan W. Dunton, by Stephen A. Slusher, Attorney-in-Fact  
**Date:** 2025-12-11

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**